This business is currently listed for sale.
Rash Scan
iOS health app featuring rash scanner, cosmetic scanner, and medication reminder. Subscription-based with strong margins and ready for scaling.
Est. Valuation
$46K
$45,960 · 5× ARR estimate
Monthly Revenue (MRR)
$766
$766/mo
Annual Revenue (ARR)
$9.2K
$9,192/yr
Founded
2025
Rash Scan Revenue History
Revenue history for Rash Scan from 2026 to 2026.
| Year | MRR | ARR | YoY Growth | Source |
|---|---|---|---|---|
| 2026 | $766 | $9,192 | — | May 2026 |
Rash Scan Funding
Rash Scan is fully bootstrapped with no outside funding. The company has grown to $9,192 ARR organically.
Rash Scan Founders
El-mostafa Akaoui
Rash Scan FAQ
How much does Rash Scan make?
What is Rash Scan's valuation?
Who founded Rash Scan?
Is Rash Scan bootstrapped?
Is Rash Scan for sale?
Companies Similar to Rash Scan
SaaS companies with similar tags and business models.
How We Estimate Rash Scan's Revenue & Valuation
Profitable tracks revenue, valuation, and other key metrics for thousands of companies using a layered confidence model. Each revenue figure on this page is tagged with one of three confidence levels:
- Verified — directly confirmed via Stripe integration or audited filings.
- Self-reported — numbers publicly shared by the founder on X, blog posts, or interviews.
- Estimated — derived from publicly available signals (traffic, employee count, pricing, comparables).
Valuation follows a hierarchy: public companies use the live market cap; private companies with disclosed funding rounds use the last reported valuation; otherwise we apply a conservative 5× ARR multiple as an estimate. Multiples vary by business model — SaaS typically sits 5–7×, profitable bootstrapped operations 3–5×, consumer brands 1–3×, marketplaces 8–12×.
These are estimates, not official figures. Official numbers — when available — will always override estimates.